glycosyl
pattern
human
vascular
endotheli
cadherin
vecadherin
purifi
cultur
human
umbil
cord
vein
endotheli
cell
analyz
vecadherin
metabol
radiolabel
h
glucosamin
isol
immunoprecipit
purifi
sdspage
ingel
digest
endoproteinas
asp
n
oligosaccharid
sequenti
releas
result
glycopeptid
analyz
chromatograph
profil
result
reveal
vecadherin
carri
predominantli
sialyl
diantennari
hybridtyp
glycan
addit
triantennari
high
mannosetyp
speci
highli
branch
tetraantennari
oligosaccharid
found
trace
amount
immunohistochem
label
vecadherin
sialic
acid
display
codistribut
along
intercellular
junction
endotheli
cell
human
umbil
arteri
vein
cultur
endotheli
monolay
ca
deplet
perform
cultur
endotheli
cell
result
revers
complet
disappear
vecadherin
almost
sialic
acid
stain
junction
sialidas
treatment
whole
cell
caus
chang
vecadherin
immunofluoresc
continu
netlik
superstructur
organ
scatter
inconsist
one
henc
cell
surfac
sialic
acid
might
play
role
vecadherin
organ
intercellular
junction
cardiovascular
endothelium
consist
variou
integr
membran
protein
abl
directli
mediat
interendotheli
adhes
ca
depend
cadherin
consist
vascular
endotheli
cadherin
telo
et
al
ncadherin
salomon
et
al
navarro
et
al
platelet
endotheli
cell
adhes
molecul
belong
ca
independ
immunoglobulin
superfamili
integrin
final
occludin
compon
tight
junction
review
see
dejana
et
al
dejana
schnittler
feldmann
vascular
endotheli
cadherin
vecadherin
endothelium
specif
suzuki
et
al
lampugnani
et
al
belong
endotheli
adheren
junction
commonli
found
endothelium
locat
situ
cultur
simionescu
et
al
simionescu
et
al
frank
et
al
frank
et
al
ca
depend
cadherin
integr
membran
protein
consist
larg
aminotermin
extracellular
domain
ectodomain
five
repeat
one
membran
span
domain
short
carboxytermin
cytoplasm
tail
takeichi
extracellular
domain
probabl
occur
parallel
strand
dimer
termin
repeat
extracellular
domain
bind
cadherin
adjac
cell
antiparallel
adhes
dimer
form
zipperlik
celltocel
connect
shapiro
et
al
b
cadherin
link
cytoplasm
actin
filament
via
plakoglobin
review
jou
et
al
klymkowski
parr
takeichi
aberl
et
al
yap
et
al
cadherincatenin
complex
epithelium
endothelium
contribut
tissu
organ
mainten
develop
adult
organ
review
see
dejana
et
al
klymkowski
parr
takeichi
aberl
et
al
yap
et
al
endotheli
cell
cadherincatenin
complex
seem
crucial
involv
certain
physiolog
pathophysiolog
reaction
regul
permeabl
extravas
leukocyt
tumor
cell
well
cell
migrat
resist
fluid
shear
stress
lampugnani
et
al
lampugnani
et
al
dejana
del
maschio
et
al
feldmann
et
al
rabiet
et
al
leval
et
al
schnittler
et
al
moll
et
al
schnittler
feldmann
polypeptid
chain
vecadherin
compris
seven
potenti
nglycosyl
site
suzuki
et
al
local
vecadherin
ectodomain
first
evid
contribut
glycan
chain
cadherin
function
epitheli
cell
obtain
yoshimura
cowork
yoshimura
et
al
demonstr
ectop
murin
melanoma
cell
express
nacetylglucosaminyltransferas
gntiii
caus
alter
glycosyl
ecadherin
turn
associ
reduc
protein
turnov
rate
increas
express
ecadherin
intercellular
junction
reduc
metastat
capac
cell
yoshimura
et
al
yoshimura
et
al
indic
glycosyl
ecadherin
involv
organ
function
compet
intercellular
junction
structur
character
glycosyl
pattern
nativ
cadherin
yet
perform
respect
import
vecadherin
particip
certain
endotheli
mediat
mechan
aim
studi
character
overal
glycosyl
pattern
vecadherin
order
enabl
function
investig
show
vecadherin
carri
predominantli
sialyl
complex
hybridtyp
glycan
sialic
acid
larg
coloc
vecadherin
molecul
interendotheli
junction
endotheli
cell
situ
cultur
cell
surfac
sialic
acid
seem
import
structur
organ
vecadherin
cluster
purif
human
vecadherin
vecadherin
obtain
human
umbil
vein
endotheli
cell
huvec
extract
vivo
label
h
glucosamin
immunoprecipit
purifi
semiprepar
sdspage
radioact
protein
band
visual
fluorographi
gel
segment
contain
vecadherin
excis
subject
carbohydr
analysi
background
control
equival
gel
segment
ii
similarli
work
lane
mass
marker
protein
lane
vecadherin
immunoprecipit
cultur
human
endotheli
cell
label
h
glucosamin
subsequ
extract
triton
buffer
describ
materi
method
use
triton
caus
releas
cadherin
catenin
complex
schnittler
et
al
immunoprecipit
g
supernat
use
monoclon
vecadherin
antibodi
precipit
protein
subject
sdspage
fluorographi
gel
display
one
main
band
mw
kda
weaker
label
band
figur
part
precipit
subject
western
blot
analysi
use
pan
cadherin
antibodi
known
react
short
carboxytermin
sequenc
classic
cadherin
antibodi
stain
singl
band
exactli
mw
main
radiolabel
band
data
shown
sinc
sd
display
sever
addit
radiolabel
protein
band
immunoprecipit
vecadherin
sampl
prepar
separ
sdspage
band
contain
vecadherin
excis
figur
order
avoid
loss
materi
elut
whole
glycoprotein
ingel
proteolyt
digest
perform
radioact
glycopeptid
could
easili
elut
gel
piec
known
amino
acid
sequenc
glycoprotein
suzuki
et
al
breviario
et
al
could
deduc
treatment
trypsin
would
gener
glycopeptid
resist
peptiden
asparagin
amidas
f
pngase
f
tarentino
et
al
therefor
aspn
endoproteinas
pseudomona
fragi
mutant
use
instead
total
glycopeptid
prepar
obtain
compris
cpm
incorpor
h
radioact
control
unstain
gel
segment
ii
figur
equal
treat
elut
howev
radioact
could
detect
respect
supernat
western
blot
analysi
use
vecadherin
monoclon
antibodi
endotheli
cell
treat
pngase
f
h
endo
h
reveal
presenc
endo
hsensit
endo
hresist
nglycan
treatment
pngase
f
result
shift
vecadherin
band
kda
kda
arrow
agreement
expect
molecular
mass
calcul
amino
acid
sequenc
figur
lane
second
band
dot
line
assum
repres
degrad
product
incub
endo
h
also
led
small
signific
shift
electrophoret
mobil
glycoprotein
figur
lane
therefor
isol
glycopeptid
first
treat
endo
h
oligosaccharid
releas
separ
residu
glycopeptid
reversephas
rp
hplc
endo
hresist
glycopeptid
incub
pngase
f
result
reaction
mixtur
subject
rphplc
isol
free
glycan
approxim
total
radioact
releas
two
enzym
residu
radioact
still
elut
peptid
fraction
could
shown
compris
exclus
nacetylglucosamin
glcnac
nacetylgalactosamin
galnac
therefor
assum
result
innermost
glcnac
residu
remain
bound
peptid
endo
h
cleavag
kobata
reduct
oligosaccharid
alditol
fraction
anionexchang
hplc
result
reveal
major
human
vecadherin
glycan
carri
neg
charg
complex
type
speci
releas
pngase
f
compris
neutral
glycan
radioact
addit
speci
one
two
three
neg
charg
residu
figur
oligosaccharid
releas
endo
h
repres
oligomannosid
hybridtyp
glycan
kobata
similarli
carri
predominantli
one
neg
charg
data
shown
treatment
sialidas
vcholera
mild
acid
hydrolysi
convert
charg
speci
neutral
compound
demonstr
neg
charg
exclus
confer
sialic
acid
case
pngase
fsensit
oligosaccharid
alditol
charg
glycan
separ
prepar
anionexchang
hplc
individu
digest
sialidas
newcastl
diseas
viru
monosialyl
speci
could
degrad
thu
sole
contain
sialic
acid
wherea
diand
trisialyl
glycan
contain
one
two
sialic
acid
residu
addit
sialic
acid
figur
character
glycan
complet
desialyl
sinc
major
endo
hsensit
glycan
carri
one
sialic
acid
residu
could
assum
repres
predominantli
hybridtyp
speci
corrobor
highph
anion
exchang
chromatographi
hpaec
desialyl
glycan
figur
speci
radioact
within
fraction
coelut
oligomannosid
standard
oligosaccharid
wherea
elut
volum
two
major
compon
correspond
oligomannosid
standard
two
hybridtyp
standard
glycan
iii
iv
geyer
et
al
respect
detail
structur
see
figur
caption
prove
ident
half
amount
endo
hsensit
compound
obtain
digest
jack
bean
rechromatographi
result
product
hpaec
demonstr
two
product
form
elut
posit
authent
manglcnacoh
galglcnacman
glcnacoh
figur
digest
second
half
sampl
figur
result
shift
elut
volum
two
hybridtyp
speci
correspond
loss
one
galactosyl
residu
wherea
elut
posit
oligomannosid
glycan
remain
unchang
therefor
may
assum
two
major
oligosaccharid
alditol
repres
hybridtyp
speci
one
nacetyllactosamin
antenna
two
three
mannosyl
residu
sensit
toward
endo
h
may
conclud
termin
mannosyl
residu
present
glycan
kobata
minor
compon
hand
repres
oligomannosid
glycan
nine
man
residu
neutral
complex
type
glycan
obtain
individu
desialyl
isocharg
speci
chromatograph
character
hpaec
figur
gel
filtrat
use
biogel
column
data
shown
although
determin
chromatograph
paramet
allow
structur
assign
priori
comparison
elut
volum
set
appropri
oligosaccharid
standard
least
two
differ
chromatograph
system
give
reliabl
result
liedtk
et
al
glucos
unit
obtain
intern
calibr
isomaltooligosaccharid
compar
authent
fucosyl
di
two
isom
tri
tetra
bisect
dianten
nari
standard
oligosaccharid
alditol
major
glycan
thu
identifi
figur
fraction
repres
fucosyl
speci
two
three
four
nacetyllactosamin
antenna
addit
speci
coelut
standard
glycan
fraction
assumpt
support
gel
filtrat
data
suggest
presenc
incomplet
triantennari
speci
lack
one
two
galactosyl
residu
substanti
assign
four
fraction
complex
type
glycan
well
respect
oligosaccharid
standard
treat
dpneumonia
result
product
analyz
hpaec
part
also
gel
filtrat
shown
figur
h
compound
identifi
fucosyl
di
tri
tetraantennari
speci
coelut
respect
agalacto
oligosaccharid
standard
treatment
speci
formerli
elut
glucos
unit
figur
b
coelut
triantennari
agalacto
oligosaccharid
standard
figur
f
thu
may
assum
compris
fucosyl
triantennari
speci
one
two
incomplet
antenna
e
differenti
possibl
isomer
form
howev
possibl
elut
posit
speci
glucos
unit
figur
chang
digest
indic
presenc
incomplet
speci
without
galactosyl
residu
elut
properti
may
conclud
also
lack
certain
extent
outer
glcnac
residu
sinc
glycan
repres
minor
constitu
number
arrow
indic
elut
volum
isomaltooligosaccharid
glucos
unit
elut
volum
fucosyl
diantennari
bisect
diantennari
isom
triantennari
tetraantennari
oligosaccharid
standard
alditol
elut
volum
respect
agalacto
oligosaccharid
standard
degalactosyl
two
triantennari
isom
bisect
diantennari
speci
coelut
ent
analyz
structur
conclus
drawn
analyt
data
describ
summar
tabl
base
glycosyl
data
describ
local
sialic
acid
ca
depend
vecadherin
studi
endotheli
cell
human
umbil
vein
arteri
situ
well
cultur
figur
control
ca
independ
also
local
figur
digoxigenin
label
maaand
snalectin
use
togeth
individu
maa
bind
sna
bind
sialic
acid
stain
intercellular
junction
well
surfac
protein
endotheli
cell
situ
figur
cultur
figur
sialic
acid
found
interendotheli
junction
larg
coloc
vecadherin
interrupt
continu
pattern
endotheli
cell
human
umbil
vein
arteri
situ
tabl
structur
propos
major
oligosaccharid
fraction
obtain
human
vecadherin
structur
deduc
analyt
result
accord
gener
rule
mammalian
glycoproteinnglycan
architectur
vliegenthart
montreuil
sharon
li
molar
ratio
roughli
estim
distribut
h
radioact
incorpor
glcnac
assum
uniform
label
linkag
posit
sialic
acid
assign
b
sialyl
variant
possibl
figur
cultur
figur
addit
overlap
junction
area
adjac
highli
confluent
endotheli
cell
netlik
distribut
vecadherin
observ
figur
b
e
larg
coloc
maasnastain
figur
netlik
structur
describ
repres
highli
order
vecadherin
organ
observ
confluent
endotheli
cell
cultur
therefor
term
vecadherin
superstructur
doubl
label
vecadherin
catenin
also
display
codistribut
highli
organ
structur
shown
label
monoclon
antibodi
partial
coloc
maasna
lesser
extent
vecadherin
figur
confirm
serial
optic
zsection
use
confoc
laser
microscopi
wherea
sialic
acid
vecadherin
primarili
local
within
apic
area
intercellular
junction
appear
resid
predominantli
basal
side
data
shown
investig
whether
junction
stain
maasna
mediat
sialic
acid
link
ca
depend
molecul
ca
deplet
experi
perform
incub
cell
monolay
mm
egta
min
lead
figur
b
weak
junction
stain
sialic
acid
leftov
ca
deplet
figur
might
caus
remain
andor
addit
ca
independ
compon
recalcif
mm
extracellular
ca
vecadherin
maasna
stain
complet
reappear
junction
within
min
figur
e
find
line
previou
observ
show
reappear
vecadherin
within
min
recalcif
ayalon
et
al
dejana
et
al
schnittler
et
al
indic
sialic
acid
locat
interendotheli
junction
predominantli
bound
ca
depend
molecul
presum
vecadherin
preabsorpt
maasna
lectin
sialyl
pig
stomach
type
iii
mucin
complet
abolish
lectin
stain
experiment
approach
treatment
cultur
endotheli
cell
sialidas
caus
complet
loss
sialic
acid
intercellular
junction
cell
surfac
protein
without
loss
monolay
integr
reveal
doublestain
sialidas
treat
cell
maasnalectin
antibodi
figur
f
condit
vecadherin
chang
continu
junction
distribut
larg
scatter
morpholog
still
local
interendotheli
junction
importantli
vecadherin
superstructur
larg
disappear
show
small
protein
cluster
variou
size
indic
loss
later
adhes
vecadherin
molecul
figur
similar
result
obtain
sialidas
treatment
carri
presenc
proteas
inhibitor
rule
observ
might
due
contamin
proteolyt
activ
enzym
use
data
shown
contrast
complet
maintain
sialidas
treatment
figur
demonstr
intact
endotheli
cell
monolay
cell
remain
attach
structur
character
sugar
chain
human
vecadherin
base
chromatograph
profil
anionexchang
hplc
hpaec
gel
filtrat
combin
exoglycosidas
digest
sinc
separ
system
use
reli
differ
physicochem
paramet
comparison
chromatograph
data
oligosaccharid
standard
known
structur
allow
first
structur
assign
although
anomer
configur
linkag
posit
respect
monosaccharid
unit
unravel
case
sialic
acid
galactosyland
part
mannosyl
residu
structur
could
postul
basi
gener
rule
mammalian
glycoproteinnglycan
architectur
vliegenthart
montreuil
sharon
li
result
reveal
human
vecadherin
substitut
predominantli
total
glycan
sialyl
diantennari
complextyp
glycan
addit
sialyl
hybridtyp
speci
higher
branch
nglycan
ie
triantennari
especi
tetraantennari
chain
well
high
mannosetyp
oligosaccharid
less
abund
data
provid
evid
presenc
oligosaccharid
carri
bisect
glcnac
shown
nguyen
cowork
bovin
capillari
endotheli
cell
carbohydr
nguyen
et
al
sinc
assign
glycan
structur
sole
base
chromatograph
properti
howev
presenc
small
amount
eventu
incomplet
bisect
oligosaccharid
complet
rule
conclus
natur
human
vecadherin
appear
mainli
decor
carbohydr
restrict
branch
pattern
high
degre
sialyl
oligosaccharid
structur
prompt
us
visual
sialic
acid
residu
surfac
endotheli
cell
lectin
stain
maa
sna
besid
label
cell
surfac
protein
interendotheli
junction
strongli
stain
lectin
specif
sialic
acid
junction
appear
maasnalabel
larg
restrict
vecadherin
observ
doubl
label
wherea
appear
extend
junction
vivo
cultur
addit
although
endotheli
cell
thin
reach
seldom
height
use
confoc
laser
microscopi
allow
rough
local
resolut
techniqu
vecadherin
immunofluoresc
well
maasnalabel
appear
predominantli
apic
pole
junction
wherea
primarili
locat
basal
pole
line
previous
publish
data
obtain
immunoelectron
microscopi
demonstr
basal
local
apic
local
vecadherin
within
interendotheli
junction
ayalon
et
al
furthermor
ca
deplet
experi
show
junction
presenc
sialic
acid
well
presenc
vecadherin
revers
depend
extracellular
ca
concentr
wherea
junction
local
remain
complet
unchang
condit
addit
shown
vecadherin
ncadherin
cluster
intercellular
junction
salomon
et
al
navarro
et
al
henc
may
assum
junction
locat
sialic
acid
might
primarili
bound
vecadherin
agreement
carbohydr
analys
purifi
vecadherin
remain
weak
maa
sna
stain
ca
deplet
might
relat
ca
independ
molecul
highli
confluent
cultur
human
umbil
vein
arteri
endotheli
cell
vecadherin
appear
undisturb
continu
band
along
interendotheli
junction
overlap
endotheli
cell
junction
netlik
vecadherin
organ
visual
network
consid
extend
vecadherin
cluster
assum
consider
increas
interendotheli
adhes
properti
shown
crystal
structur
analysi
cadherin
obvious
organ
parallel
strand
dimer
interact
parallel
strand
dimer
opposit
cell
adhes
dimer
form
zipperlik
structur
shapiro
et
al
b
format
superstructur
possibl
requir
later
associ
assum
cadherin
strand
dimer
might
influenc
carbohydr
residu
discuss
contribut
glycan
chain
vecadherin
function
howev
still
contradictori
yoshimura
cowork
yoshimura
et
al
yoshimura
et
al
provid
evid
function
role
ecadherin
glycosyl
murin
melanoma
cell
transfect
nacetylglucosaminyltransferas
gntiii
cdna
show
higher
express
ecadherin
cellcel
contact
control
cell
sinc
presenc
bisect
glcnac
residu
known
block
branch
glycoproteinnglycan
schachter
schachter
fujii
et
al
respect
glycan
assum
remain
predominantli
diantennari
state
therefor
author
conclud
reduc
branch
pattern
ecadherin
glycan
induc
ectop
express
gntiii
might
respons
elev
express
cellcel
border
observ
good
agreement
result
reveal
mainli
diantennari
hybridtyp
glycan
natur
vecadherin
hand
observ
ecadherin
contain
cell
still
aggreg
tunicamycin
treatment
suggest
glycan
independ
ecadherin
adhes
function
shirayoshi
et
al
data
show
sialidas
treatment
live
endotheli
cell
caus
signific
chang
vecadherin
cellular
organ
condit
vecadherin
still
appear
interendotheli
junction
display
scatter
immunofluoresc
pattern
includ
disappear
superstructur
contrast
underw
morpholog
chang
thu
result
describ
may
least
suggest
involv
sialic
acid
residu
structur
organ
vecadherin
question
whether
find
depend
fact
sialic
acid
residu
link
vecadherin
glycan
remain
open
sinc
exclud
remov
sialic
acid
cell
surfac
may
caus
indirect
effect
vecadherin
organ
well
conclus
result
demonstr
vecadherin
substitut
oligosaccharid
side
chain
reduc
branch
pattern
highli
sialyl
sialic
acid
present
interendotheli
junction
predominantli
bound
ca
depend
molecul
sialic
acid
larg
codistribut
vecadherin
molecul
vecadherin
superstructuralbut
lost
sialidas
treatment
result
one
might
specul
vecadherin
glycan
chain
repres
backbon
present
sialic
acid
might
involv
ca
bind
thu
mainten
rodlik
vecadherin
structur
superstructur
organ
studi
requir
howev
definit
prove
influenc
carbohydr
substitu
vecadherin
function
human
umbil
vein
endotheli
cell
huvec
harvest
cultur
previous
describ
schnittler
et
al
huvec
cultur
medium
gibco
eggenstein
germani
supplement
pool
human
serum
obtain
healthi
donor
local
blood
bank
streptomycinsulf
uml
penicillin
g
sigma
deisenhofen
germani
huvec
seed
glass
coverslip
coat
crosslink
gelatin
describ
schnittler
et
al
cell
first
second
passag
use
experi
monoclon
mous
antibodi
vecadherin
purchas
biermann
gmbh
bad
nauheim
germani
polyclon
rabbit
antibodi
pan
cadherin
known
crossreact
cytoplasm
carboxytermin
domain
classic
cadherin
fitclabel
tritclabel
phalloidin
sigma
deisenhofen
germani
r
system
wiesbaden
germani
digoxigeninlabel
maa
maakia
amurensi
sna
sambucu
nigra
tritclabel
sheep
antidigoxigenin
antibodi
obtain
boehring
mannheim
germani
fluorescein
isothiocyan
fitc
tetramethyl
isothiocyan
tritc
cyanin
label
secondari
antibodi
dianova
hamburg
lectin
antibodi
phalloidin
label
fresh
human
umbil
cord
vessel
canul
perfus
medium
remov
blood
compon
subsequ
fix
formaldehyd
phosphatebuff
salin
pb
contain
mm
nacl
mm
kcl
mm
na
hpo
mm
kh
po
ph
arteri
vein
cut
process
lectin
antibodi
label
describ
cultur
human
umbil
vein
arteri
endotheli
cell
wash
serum
free
medium
subsequ
fix
formaldehyd
dissolv
pb
piec
umbil
vein
arteri
well
cultur
cell
wash
sever
time
pb
permeabil
triton
sigma
sampl
incub
digoxigenin
label
maasna
phalloidin
min
room
temperatur
mous
monoclon
antibodi
direct
vecadherin
dilut
pb
dilut
pb
overnight
sampl
wash
pb
incub
min
fitcor
goat
antimous
igg
tritclabel
sheep
anti
digoxigenin
fab
fragment
doublelabel
lectin
maa
sna
specif
antibodi
direct
vecadherin
well
cell
fix
formaldehyd
incub
contemporari
maasna
appropri
primari
secondari
antibodi
describ
sever
wash
pb
min
coverslip
mount
glass
slide
cover
glycerol
npropylgal
antifad
substanc
verifi
lectin
stain
interendotheli
junction
specif
sialic
acid
type
iii
mucin
porcin
stomach
sigma
deisenhofen
germani
use
preabsorpt
maa
sna
lectin
ethylen
glycolbi
ether
n
n
acid
egta
treatment
egta
treatment
perform
describ
elsewher
schnittler
et
al
briefli
cell
treat
mm
egta
dissolv
medium
supplement
human
albumin
essenti
free
fatti
acid
globulin
free
ca
calcul
use
ca
calcul
program
et
al
media
ph
adjust
egta
stock
solut
mm
naoh
sialidas
treatment
perform
accord
protocol
describ
previous
krempl
et
al
briefli
cell
monolay
three
time
wash
medium
contain
immunoglobulinand
fatti
acidfre
human
albumin
sigma
deisenhofen
germani
serum
subsequ
incub
highli
purifi
sialidas
clostridium
perfringen
sigma
deisenhofen
germani
muml
min
subsequ
experi
perform
presenc
sialidas
sialidas
treatment
also
perform
presenc
proteas
inhibitor
aprotinin
pepstatin
leupeptin
experiment
condit
presenc
absenc
serum
inhibitor
sialidas
treatment
caus
complet
loss
sialic
acid
cell
carbohydr
substitu
label
accord
protocol
describ
previous
geyer
et
al
briefli
huvec
passag
zero
one
cultur
cm
cultur
flask
confluenc
prior
metabol
label
monolay
wash
glucosedefici
medium
biochrom
berlin
germani
supplement
gl
fructos
pool
human
serum
obtain
healthi
donor
local
blood
bank
dialyz
glucosefre
medium
streptomycinsulf
uml
penicillin
g
cultiv
h
cell
wash
subsequ
label
h
glucosamin
amersham
buchler
braunschweig
germani
label
period
h
glucosedefici
medium
cultur
wash
pb
ml
follow
brief
rins
triton
extract
buffer
see
step
perform
buffer
use
contain
mm
phenylmethylsulfonyl
fluorid
leupeptin
aprotinin
pepstatin
sigma
cell
extract
extract
buffer
mm
trishcl
mm
nacl
mm
cacl
sodium
azid
triton
ph
use
one
cm
cultur
flask
min
incub
cell
scrape
substratum
use
rubber
policeman
subsequ
sampl
centrifug
min
g
carbohydr
substitu
vecadherin
investig
western
blot
pngase
f
endo
h
digest
huvec
scrape
cultur
flask
ml
medium
contain
pool
human
serum
leupeptin
aprotinin
pepstatin
two
wash
serumfre
medium
cell
extract
buffer
sd
octylglycosid
sonif
boil
min
centrifug
min
g
digest
pngase
f
flavobacterium
meningosepticum
aliquot
supernat
adjust
mm
sodium
acet
mm
edta
sodium
azid
ph
uml
pngase
f
use
stock
solut
sampl
incub
h
h
pngase
f
uml
ad
control
experi
perform
water
instead
enzym
treatment
endo
h
streptomyc
griseu
perform
way
use
muml
endo
h
ph
vecadherin
isol
supernat
cell
extract
immunoprecipit
use
mous
monoclon
vecadherin
antibodi
coupl
protein
g
sepharos
bead
pharmacia
upsala
sweden
incub
night
continu
rotat
sepharos
bead
wash
three
time
ml
wash
buffer
mm
trishcl
mm
nacl
mm
cacl
sodium
azid
triton
mgml
ovalbumin
ph
one
time
wash
buffer
mm
trishcl
mm
nacl
mm
cacl
sodium
azid
triton
mgml
ovalbumin
ph
sampl
dissolv
sampl
buffer
boil
min
appli
prepar
sdspolyacrylamid
gel
polyacrylamid
schnittler
et
al
electrophoresi
sd
gel
dri
radiolabel
protein
band
detect
fluorographi
gel
segment
contain
vecadherin
excis
western
blot
exactli
perform
describ
previous
schnittler
et
al
excis
gel
piec
three
sd
gel
slot
total
cut
piec
mm
extens
wash
twicedistil
water
complet
dri
speedvac
concentr
dri
gel
piec
suspend
acetonitril
mm
trishcl
ph
contain
endoproteinas
aspn
pseudomona
fragi
mutant
boehring
mannheim
germani
overnight
incub
acetonitril
buffer
enzym
ad
incub
room
temperatur
h
glycopeptid
recov
gel
piec
remov
incub
buffer
wash
gel
piec
five
time
mm
trishcl
buffer
sonic
combin
supernat
lyophil
desalt
gel
filtrat
nlink
glycan
releas
glycopeptid
sequenti
treatment
endo
h
streptomyc
plicatu
pngase
f
flavobacterium
meningosepticum
boehring
separ
residu
glyco
peptid
reduc
desalt
describ
previous
strube
et
al
geyer
et
al
geyer
geyer
desalt
glycopeptid
free
oligosaccharid
biogel
chromatographi
ionexchang
chromatographi
use
mixedb
resin
amberlit
serva
heidelberg
germani
separ
oligosaccharid
glyco
peptid
rphplc
ph
fraction
glycan
anionexchang
hplc
use
mikropak
column
varian
walnut
creek
ca
hpaec
use
carbopak
column
dionex
sunnyval
ca
well
gel
filtrat
biogel
column
perform
describ
previous
strube
et
al
geyer
geyer
liedtk
et
al
radiolabel
monosaccharid
compon
identifi
hpaec
detail
previous
geyer
et
al
glycan
enzymat
digest
sialidas
vibrio
cholera
behringwerk
marburg
germani
newcastl
diseas
viru
oxford
glycosystem
abingdon
uk
diplococcu
pneumonia
jack
bean
boehring
use
condit
describ
previous
geyer
et
al
liedtk
et
al
mild
acid
hydrolysi
glycan
hydrolyz
n
trifluoroacet
acid
min
dri
speedvac
concentr
residu
acid
remov
addit
ml
methanol
evapor
vacuum
